FDA Orange Book
Generic for Dhivy
Dhivy contains carbidopa and levodopa. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Dhivy is carbidopa and levodopa. 8 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Dhivy and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Dhivy products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 25MG;100MG | Marketed (Rx) | None | 8 | AB |
NDA 214869, held by AVION PHARMACEUTICALS LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic carbidopa and levodopa
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| DR REDDYS LABORATORIES SA | 073589 | AB (A-rated, therapeutically equivalent) | August 28, 1992 | 25MG;100MG |
| ACTAVIS ELIZABETH LLC | 074260 | AB (A-rated, therapeutically equivalent) | September 3, 1993 | 25MG;100MG |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 078536 | AB (A-rated, therapeutically equivalent) | October 28, 2008 | 25MG;100MG |
| PHARMOBEDIENT CONSULTING LLC | 090324 | AB (A-rated, therapeutically equivalent) | September 28, 2009 | 25MG;100MG |
| SCIEGEN PHARMACEUTICALS INC | 214092 | AB (A-rated, therapeutically equivalent) | May 7, 2021 | 25MG;100MG |
| RUBICON RESEARCH LTD | 216505 | AB (A-rated, therapeutically equivalent) | September 21, 2022 | 25MG;100MG |
| AUROBINDO PHARMA LTD | 216537 | AB (A-rated, therapeutically equivalent) | November 28, 2022 | 25MG;100MG |
| ASCENT PHARMACEUTICALS INC | 218939 | AB (A-rated, therapeutically equivalent) | January 14, 2025 | 25MG;100MG |
Dhivy patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 11819485 | March 28, 2039 | Method of use | U-3557 | 214869 |
| 11439613 | March 28, 2039 | Method of use | U-3557 | 214869 |
| 11033521 | March 28, 2039 | Drug product | U-219 | 214869 |
| 11033521 | March 28, 2039 | Drug product | U-3304 | 214869 |
| 11033521 | March 28, 2039 | Drug product | U-3305 | 214869 |
Dhivy NDC codes
Questions
Is there a generic for Dhivy?
Yes. The generic name for Dhivy is carbidopa and levodopa. 8 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Dhivy?
The active ingredient in Dhivy is carbidopa and levodopa, per the FDA Orange Book.
When does the Dhivy patent expire?
The last patent listed for Dhivy in the Orange Book expires March 28, 2039. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.